Loading...

Chiasma, Inc.

CHMA•NASDAQ
Healthcare
Biotechnology
$3.76
$-0.24(-6.00%)

Chiasma, Inc. (CHMA) Stock Overview

Explore Chiasma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.3/100

Key Financials

Market Cap0
P/E Ratio-2.63
EPS (TTM)$-1.57
ROE-0.84%

AI Price Forecasts

1 WeekN/A
1 Month$4.63
3 Months$3.88
1 Year Target$4.35

CHMA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Chiasma, Inc. (CHMA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $4.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.63 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for CHMAStats details for CHMA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for CHMAAnalyst Recommendations details for CHMA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.

CEO

Raj Kannan

Employees

84

Headquarters

140 Kendrick Street, Building C East, Needham, MA

Founded

2015

Frequently Asked Questions

;